Stereological analysis of hippocampus in rat treated with chemotherapeutic agent oxaliplatin

Publish Year: 1398
نوع سند: مقاله کنفرانسی
زبان: English
View: 314

نسخه کامل این Paper ارائه نشده است و در دسترس نمی باشد

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

NSCMED08_473

تاریخ نمایه سازی: 15 دی 1398

Abstract:

Background and Aim : Oxaliplatin (OX) has been widely used for treatment of colorectal and other cancers. Adverse effect of OX and other anticancer agents on cognition have been reported, but studies on the effects of chemotherapy on brain structure are scarce. This study describes the morphometrical features of the hippocampus structures in rat following OX treatment using design-based stereological methods.Methods : Ten male Wistar rats were randomized into two groups. The rats from OX group received 2.4 mg/kg OX in vehicle for five consecutive days every week for 2 weeks intraperitoneally (IP). Controls received vehicle only. Cavalieri s method and the optical fractionator method were used for volume and neuron estimation, respectively.Results : Cavalieri s method was used for to estimate volume and showed that the volume of the hippocampus was significantly decreased in OX group (31.84 ± 1.24 mm3) compared with the vehicle control group (36.95 ± 3.48 mm3). The optical fractionator method was used to estimate neuron number and showed that the number of neurons in DG, CA1 and CA3 in OX group (8.147 ± 2.84 × 105, 4.257 ± 0.59 × 105 and 2.133 ± 0.22 × 105, respectively) did not differ from those of vehicle control group (7.36 ± 1.42 × 105, 3.521 ± 0.54 × 105 and 1.989 ± 0.46 × 105, respectively).Conclusion : These findings suggested that OX treatment induce loss of hippocampal volume without neuronal loss which might help to clarify the mechanism by which OX affects cognition and to improve preventive treatment strategies.

Authors

Javad Sadeghinezhad

Department of Basic Sciences, Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran

Irmgard Amrein

Institute of Anatomy, Division of Functional Neuroanatomy, University of Zurich, Zurich, Switzerland; Department of Health Sciences and Technology, ETH, Zurich, Switzerland